CN115124530B - A kind of preparation method of evodiamine - Google Patents
A kind of preparation method of evodiamine Download PDFInfo
- Publication number
- CN115124530B CN115124530B CN202210750885.1A CN202210750885A CN115124530B CN 115124530 B CN115124530 B CN 115124530B CN 202210750885 A CN202210750885 A CN 202210750885A CN 115124530 B CN115124530 B CN 115124530B
- Authority
- CN
- China
- Prior art keywords
- evodiamine
- reaction
- aminobenzaldehyde
- quinazoline
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HMXRXBIGGYUEAX-SFHVURJKSA-N Evodiamine Natural products CN1[C@H]2N(CCc3[nH]c4ccccc4c23)C(=O)c5ccccc15 HMXRXBIGGYUEAX-SFHVURJKSA-N 0.000 title claims abstract description 36
- TXDUTHBFYKGSAH-SFHVURJKSA-N Evodiamine Chemical compound C1=CC=C2N(C)[C@@H]3C(NC=4C5=CC=CC=4)=C5CCN3C(=O)C2=C1 TXDUTHBFYKGSAH-SFHVURJKSA-N 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 26
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 claims abstract description 22
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 11
- FXWFZIRWWNPPOV-UHFFFAOYSA-N 2-aminobenzaldehyde Chemical compound NC1=CC=CC=C1C=O FXWFZIRWWNPPOV-UHFFFAOYSA-N 0.000 claims abstract description 10
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000005580 one pot reaction Methods 0.000 claims abstract description 9
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 6
- SHVJOFYRFYDESS-WEVVVXLNSA-N (ne)-n-[(2-aminophenyl)methylidene]hydroxylamine Chemical compound NC1=CC=CC=C1\C=N\O SHVJOFYRFYDESS-WEVVVXLNSA-N 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000003818 flash chromatography Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- TXDUTHBFYKGSAH-UHFFFAOYSA-N LSM-6483 Chemical compound C1=CC=C2N(C)C3C(NC=4C5=CC=CC=4)=C5CCN3C(=O)C2=C1 TXDUTHBFYKGSAH-UHFFFAOYSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 7
- WVMBPWMAQDVZCM-UHFFFAOYSA-N N-methylanthranilic acid Chemical compound CNC1=CC=CC=C1C(O)=O WVMBPWMAQDVZCM-UHFFFAOYSA-N 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 5
- -1 3,4-dihydro-β -carboline compound Chemical class 0.000 description 4
- 241001078983 Tetradium ruticarpum Species 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- KJMRWDHBVCNLTQ-UHFFFAOYSA-N N-methylisatoic anhydride Chemical compound C1=CC=C2C(=O)OC(=O)N(C)C2=C1 KJMRWDHBVCNLTQ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 238000006170 formylation reaction Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- FQNDOEJTAHJHBF-UHFFFAOYSA-N 2-methyliminoethenone Chemical compound CN=C=C=O FQNDOEJTAHJHBF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- AEKNYBWUEYNWMJ-QWOOXDRHSA-N Pramiconazole Chemical compound O=C1N(C(C)C)CCN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(CO3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 AEKNYBWUEYNWMJ-QWOOXDRHSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- SYHWDUQFWRGJGX-UHFFFAOYSA-N acetic acid;fluoroform Chemical compound CC(O)=O.FC(F)F SYHWDUQFWRGJGX-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- DMCPFOBLJMLSNX-UHFFFAOYSA-N indole-3-acetonitrile Chemical compound C1=CC=C2C(CC#N)=CNC2=C1 DMCPFOBLJMLSNX-UHFFFAOYSA-N 0.000 description 1
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000005832 oxidative carbonylation reaction Methods 0.000 description 1
- 239000002863 oxytocic agent Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明一种吴茱萸碱的制备方法,其特征在于:所述的方法采用2‑氨基苯甲醛为原料与盐酸羟胺反应得到2‑氨基苯甲醛肟,随后加入原甲酸三乙酯,串联一锅法环合反应得到3‑氧‑喹唑啉;其后,再加入叔丁基过氧化氢、色胺、三氟甲烷磺酸甲酯和六甲基磷酰三胺进行一锅法环化反应,制得吴茱萸碱。本发明方法采取二步一锅法,合成手段新颖,工艺路线简便、绿色环保,原料价格低廉、简单易得,反应条件温和,无金属和有害试剂参与反应,污染少,总收率达38.2%~47.4%,适合工业化生产。A kind of preparation method of evodiamine of the present invention is characterized in that: described method adopts 2-aminobenzaldehyde as raw material and reacts with hydroxylamine hydrochloride to obtain 2-aminobenzaldehyde oxime, then adds triethyl orthoformate, and connects one pot method Cyclization reaction obtains 3-oxygen-quinazoline; Thereafter, add tert-butyl hydroperoxide, tryptamine, methyl trifluoromethanesulfonate and hexamethylphosphoric triamide to carry out one-pot cyclization reaction, Evodiamine was obtained. The method of the present invention adopts a two-step one-pot method, novel synthesis means, simple and convenient process route, green environmental protection, low price of raw materials, simple and easy to obtain, mild reaction conditions, no metal and harmful reagents participating in the reaction, less pollution, and a total yield of 38.2%. ~47.4%, suitable for industrial production.
Description
技术领域technical field
本发明涉及有机化学技术领域,具体涉及一种吴茱萸碱的制备方法。The invention relates to the technical field of organic chemistry, in particular to a preparation method of evodiamine.
背景技术Background technique
吴茱萸碱,英文名为Evodiamine。吴茱萸是古老的传统中药植物之一,嫩果经泡制凉干后即是传统中药吴茱萸,是苦味健胃剂和镇痛剂,又作驱蛔虫药,可以作用于治疗高血压病、腹泻、胃溃疡、头疼等疾病,同时针对产妇子宫阵缩无力和出血状况起到催产剂的作用。吴茱萸碱是中药吴茱萸的主要天然生物碱成分之一,属于色胺吲哚类生物碱,长期以来在中药中用于治疗胃肠道疾病、闭经、产后出血、抗血栓、抗癌和血管舒张活性,以及对心血管和内分泌系统起到调节的作用。Evodiamine, the English name is Evodiamine. Evodia rutaecarpa is one of the ancient traditional Chinese medicine plants. After soaking and drying the tender fruit, it is the traditional Chinese medicine Evodia rutaecarpa. Stomach ulcers, headaches and other diseases, and at the same time act as an oxytocic agent for maternal uterine weakness and bleeding. Evodiamine is one of the main natural alkaloid components of the traditional Chinese medicine Evodia rutaecarpa, belonging to the tryptamine-indole alkaloids, which have long been used in traditional Chinese medicine for the treatment of gastrointestinal diseases, amenorrhea, postpartum hemorrhage, antithrombotic, anticancer and vasodilatory activities , and regulate the cardiovascular and endocrine systems.
1915年,Asahina首次把从吴茱萸果实中分离得到了有效的天然生物活性分子吴茱萸碱。1928年,Asahina和Ohta第一次合成了吴茱萸碱。在之后的几十年里,国内外都通过研究报道了多种关于吴茱萸碱及其相似物的合成方法。Mhaske等采用靛红酸酐和色胺经酰化,引入甲基,多步反应制备吴茱萸碱,反应路线多达6步。2007年,Kitajima等人报道了一种从N-甲基邻氨基苯甲酸和色胺开始的合成路线,中间通过乙酸汞介导环化生成吴茱萸碱,该反应使用了三苯基膦和乙酸汞等昂贵且对环境不友好的试剂。2013年,Richard等人利用色胺和甲酸乙酯反应亚胺酰化合成吴茱萸碱,途中采用了有毒的氧化剂参与反应以得到关键的亚胺中间体二氢咔啉。吴安心和青木胜之等人采用色胺与N-甲基靛红酸酐利用公知惯用的缩合反应方法来合成而得到吴茱萸碱(青木胜之,吴茱萸碱的制造方法,CN:201910028395.9)。熊瑜等人以色胺和N-甲基邻氨基苯甲酸为起始原料,根据Diels-Alder反应机理,以N-甲基亚氨基乙烯酮为关键中间体与3,4-二氢-β-咔啉化合物进行反应,生成的吴茱萸碱的产率能达到50.4%,提供了一条具有潜在的工业化优势制备吴茱萸碱及其衍生物的方法。吴永龙和罗海彬等人以吲哚乙腈为原料,钯碳催化氢化制备得到色胺,然后与甲酸乙酯混合成溶液进行甲酰化反应,再把反应物溶于二氯甲烷溶液中,加入三氟乙酸进行环合反应,再由N-甲基邻氨基苯甲酸与过量的氯甲酸乙酯在回流状态下制备另一中间体,最后把两种中间体在非极性溶剂体系下进行缩合反应。本发明的优点是原料来源丰富,价廉,并通过反应条件的优化,提高了收率,达到了降低生产成本的目的,具有对环境友好,适合大规模工业化生产(吴永龙,徐竹清,陈长荣,徐伟,一种吴茱萸碱的合成方法,ZL:201010265405.X;罗海彬,盛春泉,赖增伟,陈健文,张天华,一类吴茱萸碱类化合物及其制备方法与应用,CN:201710245872.8;罗海彬,吴德燕,袁素英,黄仪有,一种吴茱萸碱类化合物及其制备方法和用途,CN:202111316255.5)。彭学东等人采用色胺为原料,经过甲酰化、环化、缩合关环三步反应得到吴茱萸碱,整个过程避免了光气、氯甲酸乙酯的使用,降低了生产过程中的安全风险,极大的简化了反应步骤。同时本发明实现了生产中溶剂的套用工艺,大大降低了生产成本,具有工业化推广价值(彭学东,张梅,赵金召,一种吴茱萸碱的生产工艺及生产中回收套用溶剂的方法,CN:202011281682.X)。及方华等人以N,N-二甲基苯胺作为反应原料经氧化羰基化反应得到N-甲基靛红酸酐,再经胺解反应得到N-(2-吲哚乙基)-2-(甲氨基)苯甲酰胺,最后通过环化反应三步合成吴茱萸碱化合物(及方华,王守才,一种利用羰基化反应三步法合成吴茱萸碱的方法,ZL:201710893048.3)。In 1915, Asahina isolated the effective natural bioactive molecule evodiamine from the fruit of Evodia rutaecarpa for the first time. In 1928, Asahina and Ohta synthesized evodiamine for the first time. In the following decades, various synthetic methods of evodiamine and its analogues have been reported at home and abroad. Mhaske et al. used isatoic anhydride and tryptamine to acylate, introduced a methyl group, and prepared evodiamine in a multi-step reaction, with a reaction route of up to 6 steps. In 2007, Kitajima et al. reported a synthetic route starting from N-methylanthranilic acid and tryptamine, in which evodiamine was mediated by mercury acetate-mediated cyclization. This reaction used triphenylphosphine and mercury acetate expensive and environmentally unfriendly reagents. In 2013, Richard et al. used tryptamine and ethyl formate to react imide acylation to synthesize evodiamine. On the way, toxic oxidants were used to participate in the reaction to obtain the key imine intermediate dihydrocarboline. Wu Anxin, Aoki Katsuyuki and others used tryptamine and N-methylisatoic anhydride to synthesize evodiamine using a well-known and commonly used condensation reaction method (Aoki Katsuyuki, the production method of evodiamine, CN: 201910028395.9). Xiong Yu et al. used tryptamine and N-methylanthranilic acid as starting materials, and according to the Diels-Alder reaction mechanism, used N-methyliminoketene as the key intermediate and 3,4-dihydro-β -carboline compound is reacted, and the yield of evodiamine generated can reach 50.4%, which provides a method with potential industrial advantages for preparing evodiamine and its derivatives. Wu Yonglong, Luo Haibin and others used indole acetonitrile as raw material, palladium carbon catalytic hydrogenation to prepare tryptamine, then mixed with ethyl formate into a solution for formylation reaction, then dissolved the reactant in dichloromethane solution, added trifluoromethane Acetic acid undergoes cyclization reaction, and another intermediate is prepared from N-methylanthranilic acid and excess ethyl chloroformate under reflux, and finally the two intermediates are condensed in a non-polar solvent system. The present invention has the advantages of abundant sources of raw materials, low price, and by optimizing the reaction conditions, the yield is improved, the purpose of reducing production costs is achieved, the environment is friendly, and it is suitable for large-scale industrial production (Wu Yonglong, Xu Zhuqing, Chen Changrong, Xu Wei, A Synthetic Method of Evodiamine, ZL: 201010265405.X; Luo Haibin, Sheng Chunquan, Lai Zengwei, Chen Jianwen, Zhang Tianhua, A Class of Evodiamine Compounds and Their Preparation and Application, CN: 201710245872.8; Luo Haibin, Wu Deyan, Yuan Suying, Huang Yiyou, an evodiamine compound and its preparation method and use, CN: 202111316255.5). Peng Xuedong and others used tryptamine as a raw material to obtain evodiamine through a three-step reaction of formylation, cyclization, and condensation ring closure. The whole process avoided the use of phosgene and ethyl chloroformate, reducing the safety risk in the production process. The reaction steps are greatly simplified. At the same time, the invention realizes the mechanical application process of solvents in production, greatly reduces the production cost, and has the value of industrialization promotion (Peng Xuedong, Zhang Mei, Zhao Jinzhao, A production process of evodiamine and a method for recovering mechanical solvents in production, CN: 202011281682. X). and Fang Hua et al. used N,N-dimethylaniline as the reaction raw material to obtain N-methyl isatoic anhydride through oxidative carbonylation reaction, and then obtained N-(2-indoleethyl)-2- (Methylamino) benzamide, and finally synthesize evodiamine compound by three-step cyclization reaction (and Fang Hua, Wang Shoucai, a method for synthesizing evodiamine by three-step carbonylation reaction, ZL: 201710893048.3).
根据吴茱萸碱的结构组成,已经有几种方法来合成它。但是有的合成方法路线很复杂,总收率低。因此,开发简捷和快速的合成方法还是非常有必要的。虽然上述方法能够成功的合成吴茱萸碱,但是过程中经常需要使用一些有毒试剂并且合成路线繁琐,生成的副产物不仅对环境保护带来了很大的压力,同时也造成了很大的浪费。在这样的背景下,本发明提出一种利用2-氨基苯甲醛为原料,二步一锅法反应环化构建吴茱萸碱的新方法,反应过程条件温和,原料简单易得,无金属参与,污染少,绿色环保。According to the structural composition of evodiamine, there have been several methods to synthesize it. However, some synthetic methods have complex routes and low overall yields. Therefore, it is necessary to develop simple and rapid synthetic methods. Although the above method can successfully synthesize evodiamine, some toxic reagents are often used in the process and the synthesis route is cumbersome, and the generated by-products not only bring great pressure to environmental protection, but also cause a lot of waste. Under such a background, the present invention proposes a new method for constructing evodiamine by using 2-aminobenzaldehyde as a raw material through two-step one-pot reaction cyclization. Less and go green.
发明内容Contents of the invention
本发明的目的在于提供一种绿色环保的合成吴茱萸碱的方法。The object of the present invention is to provide a kind of method of synthesizing evodiamine that is green and environment-friendly.
本发明一种合成吴茱萸碱的制备方法采用2-氨基苯甲醛为原料与盐酸羟胺反应得到2-氨基苯甲醛肟,随后加入原甲酸三乙酯,串联一锅法环合反应得到3-氧-喹唑啉;其后,再加入叔丁基过氧化氢、色胺、三氟甲烷磺酸甲酯和六甲基磷酰三胺进行一锅法环化反应,制得吴茱萸碱;A preparation method for synthesizing evodiamine of the present invention uses 2-aminobenzaldehyde as a raw material to react with hydroxylamine hydrochloride to obtain 2-aminobenzaldehyde oxime, then adds triethyl orthoformate, and performs a one-pot cyclization reaction in series to obtain 3-oxo- Quinazoline; thereafter, adding tert-butyl hydroperoxide, tryptamine, methyl trifluoromethanesulfonate and hexamethylphosphoric triamide to carry out a one-pot cyclization reaction to obtain evodiamine;
具体过程为:The specific process is:
步骤1:合成3-氧-喹唑啉Step 1: Synthesis of 3-oxo-quinazoline
在2-氨基苯甲醛的乙醇溶液中加入碳酸钾搅拌溶解,在0℃下继续加入盐酸羟胺,经搅拌反应完全后,将原甲酸三乙酯缓慢加入至反应液中,混合均匀后再滴加冰醋酸,其后将反应体系加热至80℃进行回流反应完全后,加入饱和NaHCO3溶液,产物冷却至室温,析出的固体经无水乙醚洗涤、乙酸乙酯重结晶,得到3-氧-喹唑啉;其中,原甲酸三乙酯、2-氨基苯甲醛、碳酸钾、盐酸羟胺的摩尔比为5∶1∶1∶1.2。Add potassium carbonate to the ethanol solution of 2-aminobenzaldehyde and stir to dissolve, continue to add hydroxylamine hydrochloride at 0°C, after the stirring reaction is complete, slowly add triethyl orthoformate to the reaction solution, mix well and then add dropwise Glacial acetic acid, then heat the reaction system to 80°C for reflux. After the reaction is complete, add saturated NaHCO 3 solution, and cool the product to room temperature. The precipitated solid is washed with anhydrous ether and recrystallized from ethyl acetate to obtain 3-oxo-quinone Azoline; Wherein, the mol ratio of triethyl orthoformate, 2-aminobenzaldehyde, potassium carbonate, hydroxylamine hydrochloride is 5: 1: 1: 1.2.
步骤2:合成吴茱萸碱Step 2: Synthesis of Evodiamine
将3-氧-喹唑啉、色胺和叔丁基过氧化氢的混合物加入1,4-二氧六环溶剂中,加热至60℃搅拌反应完全后,加入六甲基磷酰三胺,并在120℃下继续搅拌反应完全;产物冷却至室温,用饱和NaHCO3溶液猝灭反应,并经乙酸乙酯萃取、无水Na2SO4干燥、抽滤和硅胶快速色谱纯化,得到吴茱萸碱;所述的3-氧-喹唑啉、色胺、叔丁基过氧化氢、三氟甲烷磺酸甲酯和六甲基磷酰三胺的摩尔比为1∶3∶3∶2∶10。Add the mixture of 3-oxo-quinazoline, tryptamine and tert-butyl hydroperoxide into 1,4-dioxane solvent, heat to 60°C and stir to complete the reaction, then add hexamethylphosphoric triamide, And continue stirring at 120°C to complete the reaction; the product is cooled to room temperature, quenched with saturated NaHCO 3 solution, extracted with ethyl acetate, dried with anhydrous Na 2 SO 4 , suction filtered and purified by silica gel flash chromatography to obtain evodiamine ; The mol ratio of the 3-oxo-quinazoline, tryptamine, tert-butyl hydroperoxide, methyl trifluoromethanesulfonate and hexamethylphosphoric triamide is 1: 3: 3: 2: 10 .
所述的叔丁基过氧化氢的规格是在癸烷溶液中为5.5M。The specification of the tert-butyl hydroperoxide is 5.5M in decane solution.
所述的硅胶快速色谱法纯化采用的试剂为石油醚和乙酸乙酯。The reagents used in the silica gel flash chromatography purification are petroleum ether and ethyl acetate.
反应方程式如下:The reaction equation is as follows:
本发明的有益效果:本发明方法采取二步一锅法,合成手段新颖,,工艺路线简便、绿色环保,原料价格低廉、简单易得,反应条件温和,无金属和有害试剂参与反应,污染少,总收率达38.2%~47.4%,适合工业化生产。Beneficial effects of the present invention: the method of the present invention adopts a two-step one-pot method, novel synthesis means, simple and convenient process route, green and environmental protection, low price of raw materials, simple and easy to obtain, mild reaction conditions, no metal and harmful reagents participating in the reaction, and less pollution , and the total yield reaches 38.2%-47.4%, which is suitable for industrial production.
具体实施方式Detailed ways
实施例1Example 1
将称量好的2-氨基苯甲醛(1.21g,10.0mmol)加入圆底烧瓶(100mL装有磁子)中,倒入30mL乙醇溶液,随后在烧瓶中加入碳酸钾(1.38g,10.0mmol)并溶解,把烧瓶放入冰盐浴中,在0℃下加入盐酸羟胺(0.83g,12.0mmol)至烧瓶中,搅拌均匀,反应10小时,TLC监测直至原料反应完全,将原甲酸三乙酯(6.7mL,40mmol)缓慢加至反应液中,并混合均匀,缓慢滴加冰醋酸(10mol%),滴加完毕后,将反应加热至80℃左右回流30分钟,TLC监测直至反应完全,停止反应冷却至室温。在混合液中加入一定量的饱和NaHCO3溶液,会有固体析出,再用无水乙醚搅拌洗涤,所得固体即为3-氧-喹唑啉化合物的粗产品,通过乙酸乙酯重结晶,可得到有3-氧-喹唑啉化合物,为白色固体1.08g,产率79%。Add the weighed 2-aminobenzaldehyde (1.21g, 10.0mmol) into a round bottom flask (100mL with a magnet), pour 30mL of ethanol solution, and then add potassium carbonate (1.38g, 10.0mmol) in the flask and dissolved, put the flask into an ice-salt bath, add hydroxylamine hydrochloride (0.83g, 12.0mmol) to the flask at 0°C, stir evenly, react for 10 hours, monitor by TLC until the raw material has reacted completely, and triethyl orthoformate (6.7mL, 40mmol) was slowly added to the reaction solution, and mixed evenly, slowly added dropwise glacial acetic acid (10mol%), after the dropwise addition was completed, the reaction was heated to reflux at about 80°C for 30 minutes, monitored by TLC until the reaction was complete, stop The reaction was cooled to room temperature. Add a certain amount of saturated NaHCO solution in the mixed solution, there will be solid precipitation, then stir and wash with anhydrous ether, the gained solid is the crude product of 3 -oxo-quinazoline compound, which can be obtained by recrystallization through ethyl acetate The 3-oxo-quinazoline compound was obtained as a white solid, 1.08 g, with a yield of 79%.
将3-氧-喹唑啉化合物(58.4mg,0.4mmol)、色胺(192mg,1.2mmol)和叔丁基过氧化氢(218μL,在癸烷溶液中5.5M,1.2mmol)的混合物在空气中加入至干燥的封管(10mL装有磁子)中,再加入1,4-二氧六环(8mL)溶剂。将封管在60℃下搅拌44小时,TLC监测至反应完全。然后加入三氟甲烷磺酸甲酯(43.8μL,0.4mmol),将反应混合物在室温下搅拌1小时后,加入六甲基磷酰三胺(0.35mL,2mmol)。随后将反应混合物在120℃下搅拌12小时,TLC板监测至反应完全,停止反应并冷却至室温。用饱和NaHCO3水溶液猝灭反应,乙酸乙酯(3×10mL)萃取。合并有机层并用无水Na2SO4干燥,随后进行抽滤,粗产物通过硅胶快速色谱纯化,得到纯的吴茱萸碱,为白色固体36.4mg,产率60%。A mixture of 3-oxo-quinazoline compound (58.4 mg, 0.4 mmol), tryptamine (192 mg, 1.2 mmol) and tert-butyl hydroperoxide (218 μL, 5.5 M in decane, 1.2 mmol) was dissolved in air was added to a dry sealed tube (10 mL with a magnet), and then 1,4-dioxane (8 mL) was added as a solvent. The sealed tube was stirred at 60° C. for 44 hours, monitored by TLC until the reaction was complete. Methyl trifluoromethanesulfonate (43.8 μL, 0.4 mmol) was then added, and after the reaction mixture was stirred at room temperature for 1 hour, hexamethylphosphoric triamide (0.35 mL, 2 mmol) was added. Then the reaction mixture was stirred at 120° C. for 12 hours, monitored by TLC plate until the reaction was complete, stopped the reaction and cooled to room temperature. The reaction was quenched with saturated aqueous NaHCO 3 and extracted with ethyl acetate (3×10 mL). The organic layers were combined and dried over anhydrous Na 2 SO 4 , followed by suction filtration, and the crude product was purified by silica gel flash chromatography to obtain pure evodiamine as a white solid, 36.4 mg, with a yield of 60%.
实施例2Example 2
将称量好的2-氨基苯甲醛(4.84g,40.0mmol)加入圆底烧瓶(250mL装有磁子)中,倒入80mL乙醇溶液,随后在烧瓶中加入碳酸钾(5.52g,40.0mmol)并溶解,把烧瓶放入冰盐浴中,在0℃下加入盐酸羟胺(3.32g,48.0mmol)至烧瓶中,搅拌均匀,反应12小时,TLC监测直至原料反应完全,将原甲酸三乙酯(26.6mL,160mmol)缓慢加至反应液中,并混合均匀,缓慢滴加冰醋酸(10mol%),滴加完毕后,将反应加热至80℃左右回流40分钟,TLC监测直至原料反应完全,停止反应,冷却至室温,在混合液中加入一定量的饱和NaHCO3溶液,会有固体析出,再用无水乙醚搅拌洗涤,所得固体即为3-氧-喹唑啉化合物的粗产品,通过乙酸乙酯重结晶,可得到有3-氧-喹唑啉化合物,为白色固体3.74g,产率72%。Add the weighed 2-aminobenzaldehyde (4.84g, 40.0mmol) into a round-bottomed flask (250mL is equipped with a magnet), pour 80mL of ethanol solution, and then add potassium carbonate (5.52g, 40.0mmol) in the flask and dissolved, the flask was put into an ice-salt bath, and hydroxylamine hydrochloride (3.32g, 48.0mmol) was added to the flask at 0°C, stirred evenly, and reacted for 12 hours, monitored by TLC until the reaction of the raw materials was complete, and triethyl orthoformate (26.6mL, 160mmol) was slowly added to the reaction solution, and mixed evenly, and glacial acetic acid (10mol%) was slowly added dropwise. After the dropwise addition, the reaction was heated to about 80°C and refluxed for 40 minutes, monitored by TLC until the raw materials were completely reacted. Stop the reaction, cool to room temperature, add a certain amount of saturated NaHCO solution in the mixed solution, there will be solid precipitation, then stir and wash with anhydrous ether, the gained solid is the crude product of 3-oxo-quinazoline compound, passed Recrystallization from ethyl acetate gave 3-oxo-quinazoline compound as 3.74 g of white solid with a yield of 72%.
将3-氧-喹唑啉化合物(292mg,2mmol)、色胺(960mg,6mmol)和叔丁基过氧化氢(1.09mL,在癸烷溶液中5.5M,6mmol)的混合物在空气中加入至干燥的圆底烧瓶中,再加入1,4-二氧六环(40mL)溶剂。将烧瓶在60℃下搅拌48小时,TLC监测至反应完全。然后加入三氟甲烷磺酸甲酯(219μL,2mmol),将反应混合物在室温下搅拌1.5小时后,加入六甲基磷酰三胺(1.75mL,20mmol)。随后将反应混合物在120℃下搅拌14小时,TLC板监测至反应完全,停止反应并冷却至室温。用饱和NaHCO3水溶液猝灭反应,乙酸乙酯(3×30mL)萃取。合并有机层并用无水Na2SO4干燥,随后进行抽滤,粗产物通过硅胶快速色谱纯化,得到纯的吴茱萸碱,为白色固体160.6mg,产率53%。A mixture of 3-oxo-quinazoline compound (292mg, 2mmol), tryptamine (960mg, 6mmol) and tert-butyl hydroperoxide (1.09mL, 5.5M in decane, 6mmol) was added in air to In the dry round bottom flask, 1,4-dioxane (40 mL) solvent was added. The flask was stirred at 60 °C for 48 hours, monitored by TLC until the reaction was complete. Methyl trifluoromethanesulfonate (219 μL, 2 mmol) was then added, and after the reaction mixture was stirred at room temperature for 1.5 hours, hexamethylphosphoric triamide (1.75 mL, 20 mmol) was added. Then the reaction mixture was stirred at 120° C. for 14 hours, monitored by TLC plate until the reaction was complete, stopped the reaction and cooled to room temperature. The reaction was quenched with saturated aqueous NaHCO 3 and extracted with ethyl acetate (3×30 mL). The organic layers were combined and dried over anhydrous Na 2 SO 4 , followed by suction filtration, and the crude product was purified by silica gel flash chromatography to obtain pure evodiamine as a white solid 160.6 mg, yield 53%.
中间体3-氧-喹唑啉化合物:yellow solid,Mp:155-156℃,yield 72%,1H NMR(400MHz,CDCl3)δ(ppm)7.66-7.76(m,2H),7.85-7.91(m,2H),9.01(s,1H);13C NMR(100MHz,CDCl3)δ124.5,125.5,129.0,130.4,131.4,131.6,139.8,140.0,149.9;IR(KBr,υ/cm-1):1861,1703,1567,1331,1193,995;HRMS(EI)calcd for C8H7N2O(M+H)+:147.0558;found:147.0561.Intermediate 3-oxo-quinazoline compound: yellow solid, Mp: 155-156°C, yield 72%, 1 H NMR (400MHz, CDCl 3 ) δ (ppm) 7.66-7.76 (m, 2H), 7.85-7.91 (m,2H),9.01(s,1H); 13 C NMR(100MHz,CDCl 3 )δ124.5,125.5,129.0,130.4,131.4,131.6,139.8,140.0,149.9;IR(KBr,υ/cm-1) :1861,1703,1567,1331,1193,995; HRMS(EI) calcd for C 8 H 7 N 2 O(M+H)+: 147.0558; found: 147.0561.
产物吴茱萸碱:White solid,Mp:244~245℃,yield 53%;1H NMR(400MHz,DMSO-d6)δ11.09(s,1H),7.81(d,J=7.6Hz,1H),7.48(d,J=7.6Hz,2H),7.38(d,J=8.4Hz,1H),7.04(tt,J=25.8,7.4Hz,4H),6.13(s,1H),4.65(dd,J=13.2,5.6Hz,1H),3.19(d,J=12.6Hz,1H),2.89(s,3H),2.79(d,J=15.6Hz,2H).13C NMR(100MHz,DMSO-d6)δ164.7,149.2,136.9,133.9,131.1,128.5,126.4,122.3,120.7,119.7,119.4,118.7,117.9,112.1,112.0,70.2,41.4,36.9,19.9.HRMS(ESI)calcd for C19H17N3O[M+H]+:304.1445,found:304.1447。Product Evodiamine: White solid, Mp: 244~245℃, yield 53%; 1 H NMR (400MHz, DMSO-d 6 ) δ11.09(s, 1H), 7.81(d, J=7.6Hz, 1H), 7.48(d,J=7.6Hz,2H),7.38(d,J=8.4Hz,1H),7.04(tt,J=25.8,7.4Hz,4H),6.13(s,1H),4.65(dd,J =13.2, 5.6Hz, 1H), 3.19(d, J=12.6Hz, 1H), 2.89(s, 3H), 2.79(d, J=15.6Hz, 2H). 13 C NMR (100MHz, DMSO-d 6 )δ164.7, 149.2, 136.9, 133.9, 131.1, 128.5, 126.4, 122.3, 120.7, 119.7, 119.4, 118.7, 117.9, 112.1, 112.0, 70.2, 41.4, 36.9, 19.9. HRMS (ESI) calcd for C 19 H 17 N 3 O[M+H] + :304.1445,found:304.1447.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210750885.1A CN115124530B (en) | 2022-06-28 | 2022-06-28 | A kind of preparation method of evodiamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210750885.1A CN115124530B (en) | 2022-06-28 | 2022-06-28 | A kind of preparation method of evodiamine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115124530A CN115124530A (en) | 2022-09-30 |
CN115124530B true CN115124530B (en) | 2023-04-07 |
Family
ID=83379751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210750885.1A Active CN115124530B (en) | 2022-06-28 | 2022-06-28 | A kind of preparation method of evodiamine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115124530B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118791490B (en) * | 2024-09-11 | 2024-12-20 | 威胜生物医药(苏州)股份有限公司 | A kind of preparation method of evodiamine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101941971A (en) * | 2010-08-25 | 2011-01-12 | 杭州福斯特药业有限公司 | Method for synthesizing evodiamine |
CN107629051A (en) * | 2017-09-27 | 2018-01-26 | 桂林理工大学 | A kind of method that rutaecarpin is synthesized using carbonylation three-step approach |
CN110453242A (en) * | 2019-09-17 | 2019-11-15 | 广西师范大学 | A method for electrochemically synthesizing evodiamine |
CN113683615A (en) * | 2021-09-27 | 2021-11-23 | 南华大学 | Evodiamine derivative and preparation and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5117855B2 (en) * | 2004-08-19 | 2013-01-16 | アプライド・ジェネティクス・インコーポレーテッド・ダーマティクス | Biomimetic Ebodiartecarpa fruit extract for inflammation improvement |
-
2022
- 2022-06-28 CN CN202210750885.1A patent/CN115124530B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101941971A (en) * | 2010-08-25 | 2011-01-12 | 杭州福斯特药业有限公司 | Method for synthesizing evodiamine |
CN107629051A (en) * | 2017-09-27 | 2018-01-26 | 桂林理工大学 | A kind of method that rutaecarpin is synthesized using carbonylation three-step approach |
CN110453242A (en) * | 2019-09-17 | 2019-11-15 | 广西师范大学 | A method for electrochemically synthesizing evodiamine |
CN113683615A (en) * | 2021-09-27 | 2021-11-23 | 南华大学 | Evodiamine derivative and preparation and application thereof |
Non-Patent Citations (1)
Title |
---|
王翠玲等.吴茱萸次碱的合成进展.有机化学.2006,第26卷(第26期),第1437-1443页. * |
Also Published As
Publication number | Publication date |
---|---|
CN115124530A (en) | 2022-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017096996A1 (en) | Preparation method for cobimetinib | |
CN103319414A (en) | Improved telmisartan preparation process | |
CN115124530B (en) | A kind of preparation method of evodiamine | |
CN112239424B (en) | A kind of aristolochia alkaloid and preparation method of intermediate thereof | |
CN111100110A (en) | Process for preparing 7-piperazinylbenzothiophenes or salts thereof | |
CN116396204B (en) | Preparation method of 4,6, 7-trifluoro-1H-indole-2-carboxylic acid | |
CN118324765A (en) | Synthesis method of PI3K inhibitor Du Weili sibutra | |
CN114507240A (en) | Preparation method of cyclobutane tetracarboxylic dianhydride | |
CN107298694A (en) | The synthetic method and its intermediate of shellfish cholic acid difficult to understand | |
CN113912609B (en) | Preparation method of natural alkaloid tryptanthrin and derivatives thereof | |
CN117024295A (en) | Photo-induced amide dealkylation method and application thereof | |
CN104072495A (en) | Method for preparing natural product alkaloid Aaptamine | |
CN115677636A (en) | Preparation method of 2, 3',4' -biphenyl tetracarboxylic dianhydride | |
CN109134351B (en) | The synthetic method of S-3-(4-aminophenyl) piperidine | |
CN115594639A (en) | A kind of Tegrazan key intermediate synthetic method | |
CN116621754A (en) | The preparation method of pyrrolidone-3-β'-amino derivatives | |
CN114478290A (en) | Synthetic method of oseltamivir intermediate | |
CN112358447B (en) | Synthesis method of 7-fluoroisoquinoline-1-carboxylic acid | |
CN115141199B (en) | Novel method for synthesizing rutaecarpine | |
CN111100042A (en) | Preparation method of 2-methoxy-5-sulfonamide benzoic acid | |
CN115594689B (en) | Synthesis method of Rayleigh Lu Geli intermediate and Rayleigh Lu Geli | |
CN111072513B (en) | Preparation method of hepatitis drug intermediate | |
CN109824537B (en) | Preparation method of N- (3-acetyl-2-hydroxyphenyl) acetamide | |
CN117024342B (en) | A method for synthesizing phenanthridine OLED material | |
CN112142661B (en) | Synthesis method of 3-aminoquinoline-5-carboxylic acid methyl ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |